“We are delighted to welcome Andreas Amrein as Chief Executive Officer of Stallergenes Greer. He joins our company at a time of strong opportunity for continued expansion and development within ...

Stallergenes Greer, a global leader in allergy therapeutics, today announced that the Board of Directors has appointed Andreas Amrein as Chief Executive Officer, with effect from April 1, 2025 ...